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Accurate malaria diagnosis is foundational for control and elimination, and Haiti relies on HRP2-
based rapid diagnostic tests (RDTs) identifying Plasmodium falciparum in clinical and 
community settings. In 2017, one household and two easy-access group (EAG) surveys tested 
all participants (N=32,506) by conventional and high-sensitivity RDTs (cRDT/hsRDT). A subset 
of blood samples (n=1,154) were laboratory tested for HRP2 by bead-based immunoassay and 
for P. falciparum 18S rDNA by PET-PCR.  Both RDT types detected low concentrations of 
HRP2 with sensitivity estimates between 2.6 and 14.6 ng/mL. Compared to the predicate HRP2 
laboratory assay,, RDT sensitivity ranged from 86.3% to 96.0% between tests and settings, and 
specificity from 90.0% to 99.6%. In the household survey, the hsRDT provided a significantly 
higher number of positive tests, but this represented a very small proportion (<0.2%) of all 
participants. These data show an hsRDT may have limited utility in a malaria elimination setting 
like Haiti.  
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 Field-deployable diagnostic tests for malaria serve to allow reliable confirmation of 
infection and appropriate malaria case management [1]. A Plasmodium falciparum species-
specific antigen, histidine-rich protein 2 (HRP2), is the most common RDT antigenic target in P. 
falciparum endemic settings due to its high expression level and multi-epitope avidity [2, 3], 
though it is known to linger for weeks to months in human circulation following clearance of 
parasites [4]. Recent improvements to malaria RDTs include the enhanced sensitivity of antigen 
detection as well as new antigenic targets more useful for identifying non-falciparum malaria 
infections [5].  
 As a nation approaches malaria elimination, a higher proportion of all infections are 
asymptomatic and do not exhibit treatment-seeking behavior, and monitoring changes in true 
infection prevalence over time (or changes due to an intervention) becomes particularly difficult 
[6-9]. The nation of Haiti is currently focused on interruption of local malaria transmission, and 
identification of a high proportion of all infections is paramount (www.malariazeroalliance.org) 
[10]. Within this endeavor, the recently developed high-sensitivity RDT (hsRDT, SD Bioline) is 
being evaluated in direct comparison with a conventional RDT (cRDT) produced by the same 
manufacturer. Both tests exclusively detect the P. falciparum HRP2 antigen, and performance 
characteristics for these two tests have been considered in other areas of the world from 
previous studies: Myanmar [11, 12], Uganda [12], and Tanzania [13].    
 As part of ongoing elimination efforts, three surveys were completed in Haiti in 2017. 
Two of these occurred in different transmission settings in the country and utilized an easy-
access group (EAG) sampling design within schools, health facilities and churches. A third 
survey was performed in a low-transmission setting using a simple random sample of 
households from a census-based sampling frame. In total, 32,506 persons who were enrolled 
from these three surveys received both a cRDT and hsRDT diagnostic test for presence of P. 
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RDTs, and evaluation of test performance of a subset of these samples in comparison with a 
bead-based laboratory assay for the HRP2 antigen and 18S rDNA PET-PCR assay for P. 
falciparum DNA.  
 
Methods 
Human subjects  
 For all surveys, laboratory staff did not have access to personal identifiers. Persons 
consented for diagnostic tests and blood sample assays for markers of malaria. Activity did not 
constitute engagement in human subjects research as determined by the CDC Center for 
Global Health Human Subjects office (#2016-135a), and field activities received approval from 
Haitian Ministry of Public Health and Population Bioethics Committee (Comité National de 
Bioéthique) and the Institutional Review Boards (IRBs) of Tulane University and the London 
School of Hygiene & Tropical Medicine.   
 
Participant Enrollment 
Information regarding participant consent for surveys is presented in Supplementary 
Data. EAG surveys received approval from the Haitian Ministry of Public Health and Population 
Bioethics Committee (Comité National de Bioéthique)(#1516-30), and the Institutional Review 
Boards (IRBs) of Tulane University (#794709), and the London School of Hygiene & Tropical 
Medicine (#10393). A single finger-prick was performed on consenting participants to collect 
capillary blood for cRDT (SD Bioline Malaria Antigen P.f.; 05FK50; Standard Diagnostics), 
hsRDT (also known as ultrasensitive RDT, Alere Malaria Ag P.f.; 05FK141; Standard 
Diagnostics), and blood spots on filter paper (Whatman 903, GE Healthcare). Blood was dried 
on filter paper overnight, and each filter paper stored in individual baggie with desiccant at 
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Haitian national lab where they were stored at 4oC until laboratory processing. Individuals with a 
positive cRDT result received free treatment as per the national policy in Haiti. 
For the household survey, blood was collected for RDTs and prepared on filter papers in 
the same manner as the EAG surveys. The household survey was approved by the Haiti 
Ministry of Public Health and Population National Bioethics Committee (#1516-29 and 1617-31) 
and the IRBs of the U.S. Centers for Disease Control and Prevention (#6821) and the London 
School of Hygiene & Tropical Medicine (#10466). 
 
Selection of Samples for HRP2 Detection and DNA analysis 
Due to the inherent differences in sampling design, analyses for the two EAG surveys 
are presented together, and household survey estimates presented separately. All the 
participants from the EAG and household surveys with a positive cRDT or hsRDT were selected 
for quantification of HRP2 antigen by bead-based assay and parasite density determined by 
photo-induced electron transfer polymerase chain reaction (PET-PCR). For the EAG studies, 
selection of samples from persons not RDT positive were biased towards the venues where 
infections had been found, with 80% of samples selected from ‘high risk’ venues (meaning at 
least 1 RDT positive was identified). Additional samples from persons sampled in the ‘low risk’ 
venues (no RDT positives) were randomly selected until a sample size of 300 for Artibonite EAG 
and 750 for Grand Anse EAG was reached.  
Only RDT positive persons were selected from the household survey for further 
laboratory analysis. Of 161 persons in whom either RDT was positive (and results were 
available for both RDT types), 153 (95.0%) had a blood sample available for antigen detection 
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Laboratory assays for HRP2 and parasite DNA 
 Presence and quantification of antigens utilizing bead-based Luminex® based MAGPIX 
platform (Luminex Corp., Austin, TX)[14], and parasite DNA detected by PET-PCR [15] was 
performed as described in Supplementary Data.  
 
Statistics 
 A logistic regression model was fit to the HRP2 concentration versus RDT result dose–
response data, and was used to estimate the HRP2 concentrations at which 50, 75, 90, and 
95% of the RDTs would be expected to be positive in the study population [16]. Both locally 
estimated scatterplot smoothing (LOESS) and logistic regression curves with 95% confidence 
intervals were created by the R software version 3.3.0 using the stats package (R Foundation 
for Statistical Computing). Characteristics of test performance through receiver operating 
characteristic curve (ROC) analysis was performed through the SAS PROC LOGISTIC 
command with the ROC statement (SAS v9.4). Youden’s J statistic as a measure of 
informedness was calculated for each RDT for each of the two EAG surveys by the equation J = 
sensitivity – specificity – 1 [17]. Testing for statistical significance between estimated parasite 
densities of cRDT versus hsRDT results (in Figure 3, Table 2) was performed by the PROC 
TTEST procedure in SAS. All Cohen’s kappa statistics were generated in SAS. McNemar’s Chi-
square statistic with one degree of freedom was generated for age categories within the 
household-based survey, but modified by the Edwards continuity correction due to low numbers 
of discordant results [18], and test statistic generated by the equation:  
𝜒2 =  
(|𝑏 − 𝑐| − 1)2
𝑏 +  𝑐
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Presentation of results by separate sampling designs 
The majority of RDT positives in the two EAG surveys were found in the treatment 
seeking population, with 74.5% (301/404) of all RDT positive persons enrolled at health 
facilities. Conversely, all persons enrolled from the household survey were at their residence at 
time of enrollment, so not seeking standard medical treatment by definition. Due to this inherent 
difference between the EAG and household survey participant enrollment, and the fact that 
symptomatic malaria infections will skew blood antigen concentrations higher, results are 
presented separately for these two survey types.      
 
RDT concordance and test results relative to blood HRP2 concentration  
 Five additional HRP2-positive persons were found by the hsRDT for the Artibonite EAG, 
and fourteen additional positives in the Grand Anse EAG survey (Figure 1A, and 1B 
respectively). Additional hsRDT positives represented a 10.2% increase in RDT+ numbers in 
Artibonite and 3.9% increase in Grand Anse, with only the augmented numbers in the Grand 
Anse EAG significantly different. For both surveys, agreement was strong between the reported 
results for the two RDTs, with a Cohen’s kappa coefficient of 0.946 for the Artibonite EAG and 
0.978 for the Grand Anse EAG. Of 1,001 blood samples selected for further laboratory analyses 
(RDT concordance for these in Supplementary Figure 2), both parametric and non-parametric 
regression models provided a similar dose-response relationship with high convergence for both 
survey sites and RDTs (Figure 1C and D). One visible deviation among the LOESS and logistic 
curves occurred due to a single blood sample found to have high levels of HRP2, but that 
participant’s RDT results were called negative (Figure 1C). Estimates are provided for each 
RDT and EAG study site for test sensitivity at 50%, 75%, 90%, and 95% confidence of a 
positive test result at a given concentration of HRP2 antigen in the person blood sample (Table 
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EAG survey locations were similar and had overlapping confidence intervals, but estimates 
began to diverge by survey location as level of confidence increased. At the 95% confidence 
level, estimates for HRP2 concentration were significantly different for the cRDT between the 
Artibonite and Grand Anse EAGs (2.84 versus 14.61 ng/mL respectively). No significant 
differences were observed between the cRDT and hsRDT estimates within the same survey 
area for any of the confidence levels. 
 Histograms showing the entire range of HRP2 concentrations for the samples 
designated for laboratory analysis are shown in Supplementary Figure 3, and many more 
persons selected from Grand Anse were positive for HRP2 (n=322, 45.9%) than from Artibonite 
(n=50, 16.7%). As the difference in dose-response regression estimates for HRP2 concentration 
at the 95% confidence level was minor between the two RDT types, few additional positives 
would be predicted to be discovered by the high-sensitivity test (as reflected by the actual 
counts in Figure 1A, B).   
In direct comparison with the bead-based HRP2 laboratory assay, both RDT types 
performed well at both survey sites with receiver operating curve (ROC) area under the curve 
(AUC) values 0.93 or greater when modeling for RDT result based on HRP2 antigen positivity 
(Figure 2). If considering the laboratory assay to be the gold standard for HRP2 detection, the 
cRDT had sensitivities of 86.3% and 95.0% at the Artibonite and Grand Anse sites, respectively, 
and specificities of 99.6% and 92.9%. The hsRDT had slightly higher sensitivities of 88.2% and 
96.0% at the Artibonite and Grand Anse sites, but slightly lower specificities of 98.0% and 
90.0%.                     
 
RDT result relative to estimated parasite density at time of sampling 
  Though the only target for these RDTs was the HRP2 antigen, comparison to P. 
falciparum parasite densities provides valuable information regarding the utility of the tests to 
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did not have detectable P. falciparum parasite DNA, and persons with positive RDT results had 
evidence of P. falciparum DNA >80% of the time for both surveys and both tests (Table 2). No 
statistically significant differences were observed in comparing the mean estimated parasite 
densities among all four RDT negative categories ([two RDT categories] x [two survey sites]), or 
among all four RDT positive categories.  
 Dose-response modelling of cRDT and hsRDT result as a function of estimated parasite 
density is shown in Supplementary Figure 4. Since so few RDT negative persons were found to 
harbor P. falciparum DNA, the logistic sigmoidal curve did not reach a lower asymptote, and 
estimates for lower levels of RDT performance could not be derived. For both RDT tests at both 
survey sites, reliability of a positive RDT test in identifying active P. falciparum infections was 
shown to decrease only at the lowest estimated parasite densities (under 100 p/uL).  
 
Household survey cRDT and hsRDT concordance and differences in HRP2 antigen and 
parasite densities   
 In the Artibonite household survey, 21,517 persons were administered both types of 
RDTs, and agreement between the cRDT and hsRDT was strong for all age categories: 0–5, 6–
15, and >15 years (Figure 4A). Persons tested cRDT negative but hsRDT positive in all three 
age categories, with increasing test statistic of discordant results as age increased. Among the 
three age categories, only slight variation was observed in the distribution of HRP2 
concentrations among the RDT positive persons (Supplementary Figure 5), and positive 
correlation was observed for antigen concentration and parasite density (Supplementary Figure 
6). One person tested positive by cRDT, but negative by hsRDT, but a blood sample was not 
available for investigation of HRP2 antigen or parasite presence. Overall, the hsRDT identified 
36 more HRP2 positive persons (28.8% more positives than the cRDT alone), but this only 
represented 0.17% of the total study population. Highly significant differences were seen in 
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(median = 23,577 pg/mL) or the hsRDT only (median = 1,168 pg/mL) (Figure 4B). Additionally, 
highly significant differences were observed in PET-PCR estimated parasite density in persons 
testing positive by both RDTs (median = 8.64 p/uL; range: 0.0-2045.8 p/uL) or the hsRDT alone 
(median = 0.90 p/uL; range: 0.0-11.4 p/uL).     
 
cRDT to hsRDT comparison summary across all three surveys 
 In total, 32,506 total persons had both a cRDT and an hsRDT performed. Of these, 565 
(1.74%) tested positive by any RDT. Of these 565 positives, 509 (90.1% of all positives, 1.57% 
of total population) were positive by both RDTs, 55 (9.73% of all positives, 0.17% of total 
population) were positive by only the hsRDT, and 1 person was positive by only the cRDT.  
 
Discussion 
A nation faces many challenges as it progresses from very low malaria to no malaria, 
and traditional field diagnostic tests of microscopy and cRDTs were not designed for detecting 
low-density infections [7, 19]. Newer field-deployable diagnostics have undergone testing in field 
settings with promising results in their ability to detect low-density P. falciparum infections by 
molecular [20-23] and antigen detection [11, 12] methods. Though these high-sensitivity field 
diagnostic tests consistently detect more infections than their conventional counterparts of 
microscopy or cRDT, the significance of detected very low-density infections is still being 
investigated with respect to potential transmissibility and overall population-based estimates [24, 
25].  
Transmission of P. falciparum in Haiti is seasonal and heterogeneous [26-28] with some 
regions of the country estimated to have parasite prevalence exceeding 5%, whereas other 
regions have a complete absence of reported malaria [10, 29]. This current study included two 
sites in Haiti representing two different transmission strata: Grand Anse as the area of the 
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falciparum prevalence [10] (and internal data from national malaria program). A previous 
Artibonite prevalence estimate of P. falciparum infection was approximately 3% with most of 
these individuals being asymptomatic carriers at the time of the survey [28]. For this current 
study, EAG test positivity rates for any RDT in Artibonite and Grand Anse confirmed the 
disparity in number of P. falciparum infections with 0.83% (49/5876) of participants in the 
Artibonite EAG and 7.1% (355/5014) of participants in the Grand Anse EAG surveys testing 
RDT positive. If assessing the added number of positives provided by the hsRDT in these two 
surveys, 0.08% more of the sampled population in Artibonite (5 persons) and 0.28% more in 
Grand Anse (14 persons) had levels of HRP2 antigen low enough to be missed by the cRDT, 
but detectable by the hsRDT. This finding has been observed previously, with a low overall 
percentage of the study population found to harbor HRP2 antigen levels in the “opportunistic” 
zone of detection between the sensitivities of the two tests [12, 25]. However, studies in some 
higher-transmission settings have found considerably greater percentages of the population that 
tested positive with an hsRDT alone [11, 12]. Even within a country of heterogeneous 
transmission patterns, the hsRDT may have value for some areas in providing more accurate 
(and substantial) prevalence estimates, yet not be significantly advantageous over a cRDT in 
other settings. Importantly, most (75%) of the RDT positive persons from the Haiti EAG surveys 
came from treatment-seeking individuals enrolled in health facilities, and higher parasite and 
antigen densities would negate any benefit of detecting low levels of the HRP2 antigen [13].  
A key factor of RDT performance is overall HRP2 carriage in the population, which itself 
is determined by the level of P. falciparum infection [30], recent infection (lingering HRP2 in host 
blood [4, 31]), and potential accumulation of HRP2 from tandem and/or frequent infections. In 
the lower-transmission Artibonite setting, there was only a small number of individuals with 
HRP2 levels near RDT detection limits. However, in Grand Anse, where many more infections 
were found (and higher likelihood of P. falciparum exposure in the preceding few months), a 
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the hsRDT an opportunity to be the sole detector of these low HRP2 concentrations. Antigen 
persistence potentially explains our finding in the higher-transmission Grand Anse setting: 
18.4% of hsRDT positive persons were not found to have P. falciparum DNA. However, some of 
these "false positive" tests may have actually been very low density infections undetectable by 
the PET-PCR assay since this nucleic acid assay is less analytically sensitive than the hsRDT 
[15, 30]. Additionally, sampling from this one point in time does not take into account 
fluctuations of parasites through replication cycles or parasite load from the recent past. Though 
being a “false positive” in the sense of no active parasitemia, detection of the HRP2 antigen 
following a P. falciparum infection could still be useful indicator for a malaria program as a clear 
proxy of current or recent P. falciparum exposure at individual and population levels [14].       
Among both tests and both EAG sites, overall sensitivity and specificity estimates were 
high (86.3% or greater) when defining the laboratory HRP2 detection assay test as the gold 
standard. Though cRDT and hsRDT performance within a single study site was basically 
equivalent, consistent differences were seen between surveys with both types of RDTs 
providing a lower sensitivity in Artibonite, but higher specificity. The Youden’s J statistic (as a 
measure of a probability of making an informed decision with 1.0 being perfect decision making 
[17, 32]) was strong for all scenarios with values of 0.86 or higher. In Grand Anse, multiple 
samples were positive by the HRP2 lab assay only, but an even higher number of persons were 
RDT+ only for both RDT types. The RDT+s only would lower specific estimates, but this is 
potentially an artificial depression due to inherent differences in the RDT and laboratory tests. 
The field RDT uses fresh, undiluted blood immediately drawn from a participant, whereas the 
sample type for the laboratory test dried blood on filter paper. To rehydrate blood and remove 
from filter paper, an intrinsic dilution of the blood sample is needed [14]. Additionally, antigen 
degradation is possible from drying of blood, storage conditions, or length of storage. Even with 
the increased detection limit of the laboratory test, some very low HRP2 concentrations have 
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Active P. falciparum infections detected from the household survey in Artibonite were 
typically found to be low density, with 80.3% under 100 p/µL and 54.9% under 10.0 p/µL. Of 
21,591 persons in the household survey, 0.72% of 0–5 year olds, 1.1% of 6–15 year olds, and 
0.59% of >15 year olds tested positive by any RDT. Concordance between the cRDT and 
hsRDT was very good, alluding to the high sensitivity and specificity in detecting HRP2 antigen 
in participants’ blood. Though the hsRDT detected statistically-higher number of positives in all 
age categories, this was 0.2% or less from any category, and 0.17% overall regardless of age. 
In endemic settings, younger persons are at greater risk for high-density P. falciparum 
infections, whereas older individuals more able to suppress parasite replication [33, 34], but our 
study found little difference in the distribution of HRP2 concentrations among age categories. 
Comparison of persons testing positive to both RDTs versus the hsRDT alone found 
significantly lower antigen (and parasite) levels in persons detected by the hsRDT alone, but 
there was simply just a low number of Artibonite residents with these low antigen levels at the 
time of sampling.     
In the malaria elimination setting of Haiti, both conventional and high-sensitivity HRP2-
based RDTs performed well, and high concordance between the two tests was observed in two 
different transmission zones. In comparison with the cRDT, statistically higher numbers of 
positive tests were observed with the hsRDT, supporting the increased HRP2 detection capacity 
of this test, but this was a very small percentage of the overall population sampled. These 
findings are in line with other studies in malaria elimination settings that have noted more 
positives when employing the hsRDT, but that these slightly higher estimates do not change the 
overall prevalence for relevant programmatic purposes. Though likely of limited utility in the 
Haitian setting, further evaluation of novel antigen-based tests is warranted to investigate utility 
in different transmission settings, P. falciparum genotypes, and human populations. As 
innovative diagnostics are introduced, increased performance of a novel test in a population will 
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Figure 1. Concordance between test results for the two types of RDTs in Artibonite and 
Grand Anse EAG surveys and dose-response relationship between HRP2 antigen 
concentration and RDT result. Panels are shown for the Artibonite and Grand Anse study 
sites for the conventional and high-sensitivity RDTs (cRDT/hsRDT). Two-by-two tables for the 
two RDTs comparing test concordance for all persons enrolled in the Artibonite (A) and Grand 
Anse (B) surveys with Cohen’s kappa agreement. *, McNemar’s test to indicate statistical 
significance of discordant test results between the two RDTs was modified to adjust for low 
numbers of discordant results as described in Methods. Logistic and LOESS regression of 
probability of RDT positivity by antigen concentration in study participants for Artibonite (C) and 
Grand Anse (D) surveys. Outputs for the logistic regression shown in Table 1. 
 
Figure 2. Performance of the two RDT tests in comparison with the laboratory HRP2 bead 
assay. Two-by-two tables, ROC curves, and performance measures shown for the two EAG 
study sites for the two types of RDTs employed. PPV: positive predictive value, NPV: negative 
predictive value, AUC: area under the curve.   
 
Figure 3. Estimated P. falciparum parasite densities by RDT result. Panels are shown for 
the Artibonite and Grand Anse EAG study sites and categories indicate negativity or positivity to 
the conventional RDT (cRDT) or high-sensitivity RDT (hsRDT). Horizontal bars show median 
parasite density as estimated by PET-PCR for the respective category.    
 
Figure 4. Concordance of conventional RDT and high-sensitivity RDT test for large 
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categories: 0-5, 6-15, and >15 years of age, with estimates for Cohen’s kappa statistic for 
agreement between the two types of RDTs. *, McNemar’s test to indicate statistical significance 
of discordant test results between the two RDTs was modified to adjust for low numbers of 
discordant results as described in Methods. Differences in HRP2 antigen levels (B) and PET-
PCR estimated parasite density (C) for blood samples from persons testing positive for both 
RDTs, or hsRDT only. Antigen levels are log-transformed and normal and kernel distributions 
overlaid. Boxes are 25% and 75% percentile with horizontal line displaying median. Whiskers 
display minimum and maximum values within 1.5 interquartile range and circles are outliers 
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Table 1. Modelled Concentrations of HRP2 Detection by Probability of a Positive Test for 


















 HRP2 concentration (ng/mL) (95% CI) 
Sensitivity Artibonite cRDT Artibonite hsRDT Grand Anse cRDT Grand Anse hsRDT 
50% 0.318 (0.18-0.66) 0.213 (0.12-0.46) 0.458 (0.32-0.66) 0.326 (0.23-0.47) 
75% 0.719 (0.33-1.5) 0.542 (0.24-1.2) 1.659 (1.0-2.6) 1.216 (0.77-1.9) 
90% 1.623 (0.52-3.6) 1.379 (0.42-3.3) 6.012 (3.2-11) 4.538 (2.4-8.1) 
95% 2.849 (0.65-6.4) 2.607 (0.54-6.4) 14.61 (6.5-27) 11.19 (4.8-21) 
HRP2: histidine-rich protein 2 
CI: confidence interval 
cRDT: conventional rapid diagnostic test 
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Table 2. PCR Positivity and Estimated Parasite Density by RDT Result 
 
 




Estimated parasite density 
of DNA positives (p/μL) 
Artibonite cRDT     
          Positive 88.4 511.4 
          Negative 4.5 6.7 
Artibonite hsRDT   
          Positive 85.4 463.2 
          Negative 3.3 10.3 
Grand Anse cRDT   
          Positive 84.0 1009.9 
          Negative 6.6 15.7 
Grand Anse hsRDT   
          Positive 81.6 998.1 
          Negative 5.6 15.6 
Pf: Plasmodium falciparum  
DNA: deoxyribonucleic acid  
cRDT: conventional rapid diagnostic test 
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